Long-Term Benefit in HF Patients Elusive for Novel Vasodilator

–Investigational drug ularitide had no effect on mortality or clinical outcomes NEW ORLEANS — Short term vasodilator treatment for acute heart failure in the hospital did not lead to long term clinical benefits in the largest and most rigorous trial in the field yet performed, researchers said. In the TRUE-AHF trial 2,157 patients with acute...Click here to continue reading...
Source: CardioBrief - Category: Cardiology Authors: Tags: Heart Failure acute heart failure ADHF Cardiorentis ularitide vasodilator Source Type: blogs